Why is Fermenta Biotech Ltd falling/rising?

Strong Relative Performance Against Benchmarks

Fermenta Biotech’s recent price action stands out markedly when compared to the broader Sensex index. Over the past week, the stock has appreciated by 3.80%, while the Sensex declined by 1.87%. This trend extends over longer periods as well, with the stock gaining 5.62% in the last month against an 8.51% fall in the Sensex. Year-to-date, Fermenta Biotech has managed a positive return of 3.22%, contrasting sharply with the Sensex’s 11.67% decline. Even on a one-year horizon, the stock has surged 30.14%, significantly outperforming the Sensex’s modest 3.52% loss. These figures highlight the company’s resilience and appeal amid broader market volatility.

Over a three-year span, Fermenta Biotech’s returns have been particularly impressive, soaring 176.31% compared to the Sensex’s 30.85%. Although the five-year return of 39.12% trails the Sensex’s 55.39%, the recent momentum suggests renewed investor interest and potential for further gains.

Intraday Strength and Technical Indicators

On 25-Mar, Fermenta Biotech touched an intraday high of ₹362, representing a 5.93% gain from previous levels. The stock’s closing price of ₹359.20 reflects sustained buying interest throughout the trading session. Notably, the weighted average price indicates that a larger volume of shares traded closer to the day’s lower price, suggesting some profit-taking or cautious trading near the session’s peak.

From a technical standpoint, the stock is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment signals a strong bullish trend and may encourage further accumulation by momentum-driven investors. The consecutive gains over the last two days, amounting to a 6.01% return, reinforce this positive technical outlook.

Investor Participation and Liquidity Considerations

Despite the price appreciation, investor participation appears to be waning. Delivery volume on 24-Mar was recorded at 10,880 shares, a sharp decline of 44.14% compared to the five-day average delivery volume. This drop suggests that while the stock price is rising, fewer investors are holding shares for the long term, potentially indicating short-term speculative interest or cautious positioning ahead of upcoming events.

Liquidity remains adequate for trading, with the stock’s daily traded value supporting trade sizes of approximately ₹0.02 crore based on 2% of the five-day average traded value. This level of liquidity ensures that investors can enter or exit positions without significant price impact, which is favourable for both retail and institutional participants.

Summary and Investor Implications

The rise in Fermenta Biotech’s share price on 25-Mar can be attributed to its consistent outperformance relative to the Sensex and sector indices, coupled with positive technical signals. The stock’s ability to maintain levels above key moving averages and its recent consecutive gains indicate sustained bullish momentum. However, the decline in delivery volumes suggests that investor conviction may not be uniformly strong, warranting cautious optimism.

For investors, the stock’s strong relative returns over multiple timeframes make it an attractive candidate for those seeking exposure to the pharmaceuticals and biotechnology sector with a microcap focus. The current liquidity profile supports ease of trading, though monitoring volume trends will be important to gauge the durability of the rally.

Overall, Fermenta Biotech’s price rise reflects a combination of market outperformance, technical strength, and sectoral interest, positioning it favourably amid a challenging broader market environment.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →